A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bromocriptine-13CD3 - Request Quote

Picture of Bromocriptine-13CD3

Bromocriptine-13CD3

SZ CAT No:SZ-B089D01
CAS No
NA
Mol.F.
C3113CH37D3BrN5O5
Mol.Wt.
658.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Bromocriptine-13CD3 is chemically (6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-(methyl-13C-d3)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide. Bromocriptine-13CD3 is supplied with detailed characterization data compliant with regulatory guideline. Bromocriptine-13CD3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bromocriptine Mesilate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Bromocriptine-13CD3

Purchase Bromocriptine-13CD3

Bromocriptine-13CD3 suppliers

Bromocriptine-13CD3 manufacturers

Bromocriptine-13CD3 price

Order Bromocriptine-13CD3

Enquire Bromocriptine-13CD3

Bromocriptine-13CD3 cost

Bromocriptine-13CD3 Supplier

Bromocriptine-13CD3 Distributor

Bromocriptine-13CD3 for Method Validation

Bromocriptine Mesilate Reference Standard

Bromocriptine-13CD3 for ANDA Filing

Bromocriptine-13CD3 for Forced Degradation Studies

Bromocriptine-13CD3 Identification Standards

Bromocriptine-13CD3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,